Dmitry Balyasny’s Medicines Co MDCO Stock Holding History

Dmitry Balyasny’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-405,000	Closed	-$11.3M	–	1841
2019 Q1	$11.3M	Buy	405,000 +45,000	+13%	+$1.06M	0.08%	360
2018 Q4	$6.89M	Sell	360,000 -170,500	-32%	-$3.97M	0.05%	443
2018 Q3	$17.8M	Buy	+530,500	New	+$20M	0.08%	334
2017 Q3	–	Sell	-400,000	Closed	-$15.2M	–	2182
2017 Q2	$15.2M	Buy	+400,000	New	+$17.8M	0.06%	401

Other funds holding MDCO

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Dmitry Balyasny's MDCO Position: Q1 2020 in Review

Dmitry Balyasny sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 189,165 shares — an estimated $16.1M sold.

Dmitry Balyasny first reported a position in MDCO in Q3 2013 and held it in 11 quarters. The position peaked at $16.1M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

Dmitry Balyasny reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
Dmitry Balyasny sold 189,165 Medicines Co shares in Q1 2020, an estimated $16.1M.
Dmitry Balyasny first reported a position in Medicines Co in Q3 2013 and held it in 11 quarters.
Dmitry Balyasny's Medicines Co position peaked at $16.1M in Q4 2019.
1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Balyasny Asset Management's 13F filing for Q1 2020, filed 15 May 2020.